Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Effective treatments for lichen planopilaris are unclear due to inconsistent results and a lack of strong research evidence.

The immune system plays a key role in tissue repair, affecting both healing quality and regenerative ability.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

Effective symptom management in IBD improves quality of life and prevents complications.

Hair loss is common in IBD patients, and some medications may lower the risk.

The guide helps clinicians diagnose and manage hair loss, detailing examination techniques and treatments for different types of alopecia.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Some plants may help with hair growth and have fewer side effects than synthetic drugs, but more research is needed to confirm their effectiveness.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

Stress increases a factor in mice that leads to hair loss, and blocking this factor may prevent it.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Early intervention and patient education are crucial for managing alopecia areata.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.